Planned first safety and efficacy analysis of oral fludarabine combined with subcutaneous alemtuzumab in 2(nd) line therapy of B-chronic lymphocytic leukaemia (B-CLL): The FLUSALEM study.

Egle, A, Tinhofer, I, Russ, G, Rass, C, Greil, R BLOOD. 2006, 108(11): 336B-336B.

Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.

Tinhofer I, Rubenzer G, Holler C, Hofstaetter E, Stoecher M, Egle A, Steurer M, Greil R. Blood. 2006 Nov 1,108(9):2950-6. Epub 2006 Jul 6.

The effect of IgVH mutational status on the induction of apoptosis by rituximab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: evidence from a clinical phase I/II trial.

Tinhofer I, Steurer M, Leitinger G, Rumpold H, Egle A, Erdel M, Greil R. Haematologica. 2006 Sep,91(9):1291-3.

Treatment of advanced Hodgkinxxxs disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkinxxxs Lymphoma Study Group HD6 trial

Sieber, M, Tesch, H, Pfistner, B, Rueffer, U, Paulus, U, Munker, R, Hermann, R, Doelken, G, Koch, P, Oertel, J, Roller, S, Worst, P, Bischof, H, Glunz, A, Greil, R, von Kalle, K, Schalk, KP, Hasenclever, D, Brosteanu, O, Duehmke, E, Georgii, A, Engert, A, Loeffler, M, Diehl, V ANN ONCOL. 2004, 15(2): 276-282.

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years‘ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.

Jakesz R, Jonat W, Gnant M, Mittlboeck M, Greil R, Tausch C, Hilfrich J, Kwasny W, Menzel C, Samonigg H, Seifert M, Gademann G, Kaufmann M, Wolfgang J Lancet. 2005 Aug 6-12,366(9484):455-62.

Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alpha2b as first-line chemotherapy in elderly patients with multiple myeloma.

Ludwig H, Spicka I, Klener P, Greil R, Adam Z, Gisslinger H, TarkovГЎcs G, Linkesch W, Maniatis A, Morant R, Drach J, Kuhn I, Schuster J, Hinke A. Br J Haematol. 2005 Nov,131(3):329-37.

1,10-Epoxyhypocretenolides from the Azorean Endemic Leontodon rigens (Asteraceae)

Zidorn C, Ellmerer EP, Konwalinka G, Ongania KH, Schwaha R, Greil R, Jöhrer K, Perry NB, Stuppner H Letters in Organic Chemistry. Volume 2, Number 5, August 2005 , pp. 461-464(4).

Expression levels of CD38 in tumor cells and T-cells are of prognostic value in B-CLL

Tinhofer, I, Rubenzer, G, Egle, A, Greil, R BLOOD. 2005, 106(11): 347A-347A.

Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin’s lymphoma: final results of the German Hodgkin’s Lymphoma Study Group Trial HD5.

Sieber M, Tesch H, Pfistner B, Rueffer U, Lathan B, Brosteanu O, Paulus U, Koch T, Pfreundschuh M, Loeffler M, Engert A, Josting A, Wolf J, Hasenclever D, Franklin J, Duehmke E, Georgii A, Schalk KP, Kirchner H, Doelken G, Munker R, Koch P, et al. J Clin Oncol. 2002 Jan 15,20(2):476-84.

Tetrocarcin-A–induced ER stress mediates apoptosis in B-CLL cells via a Bcl-2–independent pathway.

Anether G, Tinhofer I, Senfter M, Greil R. Blood. 2003 Jun 1,101(11):4561-8. Epub 2003 Jan 30.